NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

SMS Lifesciences India Limited (NSE: SMSLIFE)

 
SMSLIFE Technical Analysis
4
As on 23rd Apr 2024 SMSLIFE SHARE Price closed @ 692.20 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 550.91 & Buy for SHORT-TERM with Stoploss of 622.29 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

SMSLIFESHARE Price

Open 694.55 Change Price %
High 717.00 1 Day -2.40 -0.35
Low 688.40 1 Week -39.90 -5.45
Close 692.20 1 Month 71.40 11.50
Volume 4863 1 Year 135.55 24.35
52 Week High 874.85 | 52 Week Low 498.45
 
NSE INDIA Most Active Stocks
IDEA 14.40 11.63%
YESBANK 25.65 1.79%
SUZLON 41.85 2.45%
EASEMYTRIP 47.15 4.89%
RAMASTEEL 13.65 6.64%
TTML 84.90 9.27%
NHPC 89.75 1.36%
IRFC 147.75 2.53%
SAIL 152.25 2.59%
ZOMATO 187.45 -3.05%
 
NSE INDIA Top Gainers Stocks
SMARTLINK 212.70 20.00%
TEJASNET 1088.25 20.00%
OAL 383.55 19.99%
UMANGDAIRY 100.95 19.96%
ASHIMASYN 21.45 17.21%
LUXIND 1332.00 15.81%
SUDARSCHEM 717.05 13.87%
COCHINSHIP 1251.95 13.29%
INDRAMEDCO 276.25 12.66%
BSE 3199.85 12.22%
 
NSE INDIA Top Losers Stocks
ANUP 1827.25 -49.19%
ASTERDM 399.50 -22.18%
TEMBO 203.10 -10.76%
KMSUGAR 40.40 -9.92%
PALASHSECU 135.30 -9.77%
LYPSAGEMS 6.75 -6.25%
TPLPLASTEH 94.80 -5.77%
M&MFIN 263.45 -5.52%
SOLARA 547.60 -5.46%
KICL 4276.75 -5.23%
 
 
SMSLIFE
Daily Charts
SMSLIFE
Intraday Charts
Whats New @
Bazaartrend
SMSLIFE
Free Analysis
 
SMSLIFE Important Levels Intraday
RESISTANCE747.31
RESISTANCE729.64
RESISTANCE718.71
RESISTANCE707.79
SUPPORT676.61
SUPPORT665.69
SUPPORT654.76
SUPPORT637.09
 
SMSLIFE Target April 2024
4th UP Target858.65
3rd UP Target777.38
2nd UP Target727.15
1st UP Target676.92
1st DOWN Target533.58
2nd DOWN Target483.35
3rd DOWN Target433.12
4th DOWN Target351.85
 
SMSLIFE Weekly Target
4th UP Target1013.86
3rd UP Target921.22
2nd UP Target863.96
1st UP Target806.70
1st DOWN Target643.30
2nd DOWN Target586.04
3rd DOWN Target528.78
4th DOWN Target436.14
 
SMSLIFE Target2024
4th UP Target988.03
3rd UP Target841.01
2nd UP Target750.13
1st UP Target659.26
1st DOWN Target399.94
2nd DOWN Target309.07
3rd DOWN Target218.19
4th DOWN Target71.17
 
 
SMSLIFE Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 34.34 Sideways
MFI (14) MFI is Below 20 Over Sold
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is -65.00 Sideways
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Long Buy 249.45
10 Day Avg Volume Traded -82.14 % Less then 10 Day Average Volume
 
SMSLIFE Other Details
Segment EQ
Market Capital 2618773760.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
SMSLIFE Address
SMSLIFE
 
SMSLIFE Latest News
 
Your Comments and Response on SMS Lifesciences India Limited
 
SMSLIFE Business Profile
SMS Lifesciences India Limited manufactures, buys, imports, and sells active pharmaceutical ingredients (API) and its intermediates, organic and inorganic chemicals, and pharmaceuticals in India. The company offers APIs in various therapeutic areas, such as antiulcer, antifungal, and erectile dysfunction. It also provides consultancy services. The company exports its products. The company was founded in 1990 and is based in Hyderabad, India. Address: Plot No. 19-III, Hyderabad, India, 500096
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service